Clinical Trials
- Asthma, Lung
Tezepelumab COPD Exacerbation Study (COURSE)
- Ages40 years - 80 years
- GenderBoth
- Lung
Saracatinib (AZD0530) in the Treatment of Patients with Idiopathic Pulmonary Fibrosis
- Ages40 years and older
- GenderBoth
- Heart/Cardiovascular
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
- Ages18 years and older
- GenderBoth